News Releases
40 Stories Found
Moffitt Researchers Develop New Chemical Method to Enhance Drug Discovery
Moffitt Consortium Study Answers Questions About Long-Term Survivorship Following CAR T Treatment
New Moffitt Study Explores How Antifragility Could Revolutionize Cancer Treatment
Moffitt Study Uncovers Key Immune Cells for Combating Aggressive Merkel Cell Carcinoma
Tumor-Infiltrating Lymphocyte Therapy Marks a Milestone in Cancer Treatment
![Moffitt's Magnolia Campus](/contentassets/965954d6ebd043a08bded508f5207724/moffitt-bridge-image-4.jpg)
Chip Fletcher, Esq., Appointed as Moffitt Cancer Center’s General Counsel
Moffitt Researchers Develop Synthesis Method to Enhance Access to Cancer-Fighting Withanolides
Revolutionizing Ovarian Cancer Treatment With Adaptive PARP Inhibitor Therapy
Moffitt Cancer Center Achieves Prestigious Nursing Magnet Recognition
Moffitt Study Reveals New Mechanism of Drug Resistance in Melanoma Leptomeningeal Disease
Moffitt Earns 2024 LGBTQ+ Healthcare Equality Leader Designation
Engineering Cancer’s End: Moffitt Scientists Say Bioengineering Will Change Our Ability to Research and Treat Cancer
Innovative Combination Therapy Shows Promise for Bladder Cancer Patients Unresponsive to Standard Treatment
Moffitt Cancer Center and Virogen Biotechnology Forge Groundbreaking Partnership to Accelerate Oncology and Immunotherapy Innovations
Moffitt Cancer Center Uses AI to Develop More Personalized Cancer Treatment Strategies